3-Deoxy-3-acetyl abiraterone-3-ene
An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga.
Supplier | BOC Sciences |
---|---|
Product # | B0038-007224 |
Pricing | Inquire |
Molecular Weight | 373.54 |
Molecular Formula | C26H31NO |